{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:18:10Z","timestamp":1694769490395},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>p16 protein is significantly down-regulated in several cancers, which reveals that it may be a potential biomarker for cancers. However, the clinicopathological and prognostic value of p16 protein in nasopharynx cancer patients remains unclear. Therefore, we performed a meta-analysis to assess the relationships of p16 protein expression with the clinicopathological features and prognosis of nasopharynx cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PubMed, Web of Science, Embase, and Chinese CNKI were searched to obtain eligible data. The relationships of p16 protein expression with risk, clinicopathological features, and prognosis of nasopharynx cancer were analyzed with stata 14.0 software. The pooled odds ratio (OR) with 95% CI (confidence interval) and hazards ratio (HR) with 95% CI were calculated to evaluate the association between p16 protein expression and nasopharynx cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 28 studies with 2612 nasopharynx cancer patients were included in the meta-analysis. p16 protein expression was significantly associated with the risk, lymph node metastasis, TNM-stage (tumor-node-metastasis), distant metastasis, and T stage of nasopharynx cancer (Risk, OR\u200a=\u200a17.82, 95% CI\u200a=\u200a11.20\u201328.35; Lymph node metastasis, OR\u200a=\u200a2.11, 95% CI\u200a=\u200a1.42\u20133.14; TNM-stage, OR\u200a=\u200a2.25, 95% CI\u200a=\u200a1.54\u20133.28; Distant metastasis, OR\u200a=\u200a3.43, 95% CI\u200a=\u200a1.55\u20137.58; T-stage, OR\u200a=\u200a1.72, 95% CI\u200a=\u200a1.27\u20132.33). The negative rate of p16 protein expression in control group was 8.77%, while the negative rate of p16 protein expression in the nasopharynx cancer tissue was 63.78%. However, no significant associations of p16 expression with the overall survival and progression-free survival of nasopharynx cancer were found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The meta-analysis revealed that downregulated p16 expression was significantly associated with the risk, lymph node metastasis, TNM-stage, distant metastasis, and T stage of nasopharynx cancer. No significant association between p16 protein expression and prognosis of nasopharynx cancer was found. However, additional high-quality and multicenter studies should be conducted to validate these findings in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014602","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T11:46:07Z","timestamp":1552823167000},"page":"e14602","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological and prognostic significance of p16 protein in nasopharynx cancer patients"],"prefix":"10.1097","volume":"98","author":[{"given":"Lingling","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Liaocheng People's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Liaocheng Brain Hospital of Liaocheng People's Hospital, Liaocheng City, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingli","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Liaocheng People's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5732\/cjc.009.10329","article-title":"Is nasopharyngeal cancer really a \u201cCantonese cancer\u201d?","volume":"29","author":"Wee","year":"2010","journal-title":"Chin J Cancer"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199509143331103","article-title":"Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma","volume":"333","author":"Pathmanathan","year":"1995","journal-title":"N Engl J Med"},{"key":"R4-20230914","first-page":"5365","article-title":"High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese","volume":"60","author":"Chan","year":"2000","journal-title":"Cancer Res"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajhg.2009.07.007","article-title":"Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3","volume":"85","author":"Tse","year":"2009","journal-title":"Am J Hum Genet"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ijc.28802","article-title":"Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair","volume":"135","author":"Yee","year":"2014","journal-title":"Int J Cancer"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/ijc.24293","article-title":"Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China","volume":"124","author":"Guo","year":"2009","journal-title":"Int J Cancer"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2011.12.011","article-title":"Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches","volume":"22","author":"Lo","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"R9-20230914","first-page":"4119","article-title":"Sidransky D. p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro","volume":"56","author":"Liggett","year":"1996","journal-title":"Cancer Res"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/excr.1997.3824","article-title":"The tumor suppressor protein p16INK4a","volume":"237","author":"Serrano","year":"1997","journal-title":"Exp Cell Res"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000478-200204000-00009","article-title":"Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival","volume":"26","author":"Hilton","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R16-20230914","first-page":"406","article-title":"The expression of suppressor gene p16, p21 and p53 in nasopharyngeal carcinoma","volume":"13","author":"Lei Xun","year":"1999","journal-title":"J Clin Oto Rhinolaryngol (China)"},{"key":"R17-20230914","first-page":"394","article-title":"Relationship between expression of P16 protein and prognosis in carcinoma of nasopharynx","volume":"30","author":"Wang","year":"1999","journal-title":"J West China Univ Med Sci"},{"key":"R18-20230914","first-page":"182","article-title":"Expression of EGFR and p16 protein in nasopharyngeal cancer","volume":"14","author":"Mao","year":"1999","journal-title":"Pract J Cancer"},{"key":"R19-20230914","first-page":"34","article-title":"A study of CDK4 and p16 protein in nasopharyngeal carcinoma","volume":"19","author":"Dai","year":"2000","journal-title":"Chin J Cancer"},{"key":"R20-20230914","first-page":"37","article-title":"Expression and significance of E-cadherin and p16 gene in nasopharyngeal carcinoma","volume":"19","author":"Mo","year":"2000","journal-title":"Chin J Cancer"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00005537-200108000-00025","article-title":"Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma","volume":"111","author":"Huang","year":"2001","journal-title":"Laryngoscope"},{"key":"R22-20230914","first-page":"1008","article-title":"The relationship between expression of cyclin D1 protein and prognosis of poorly differentiated nasopharyngeal squamous cell carcinoma","volume":"22","author":"Liu","year":"2001","journal-title":"Guangdong Med J"},{"key":"R23-20230914","first-page":"217","article-title":"Expression of cell cycle-controlled gene in the carcinogenesis of nasopharyngeal carcinoma","volume":"23","author":"Wang","year":"2001","journal-title":"Anatom Res"},{"key":"R24-20230914","first-page":"132","article-title":"Rapid tissue microarray assay of p16 protein expression for different stage nasopharyngeal carcinoma","volume":"31","author":"Zhang","year":"2002","journal-title":"Chin J Pathol"},{"key":"R25-20230914","first-page":"706","article-title":"Expression of p16 and Rb protein in nasopharyngeal carcinoma","volume":"28","author":"Chen","year":"2002","journal-title":"Jiangsu Med J"},{"key":"R26-20230914","first-page":"11","article-title":"Abnormal expression and clinical significance of p16 protein in nasopharyngeal carcinoma","volume":"24","author":"Liang","year":"2002","journal-title":"Guangxi Med J"},{"key":"R27-20230914","first-page":"347","article-title":"Expression and clinical significance of p27kip1, p16 and proliferating cell nuclear antigen in nasopharyngeal carcinoma","volume":"32","author":"Li","year":"2003","journal-title":"Chin J Pathol"},{"key":"R28-20230914","first-page":"770","article-title":"The expression and significance of protein p16 in nasopharyngeal carcinoma","volume":"25","author":"Wei","year":"2003","journal-title":"J Youjiang Med Coll National"},{"key":"R29-20230914","first-page":"323","article-title":"Correlation between abnormal expression of p16, cyclin D1 and occurrence of nasopharyngeal carcinoma","volume":"11","author":"Yang","year":"2004","journal-title":"Chin Arch Otolaryngol- Head Neck Surg"},{"key":"R30-20230914","first-page":"892","article-title":"Clinical significance of p16 and p73 proteins expression in nasopharyngeal carcinoma","volume":"28","author":"Fan","year":"2004","journal-title":"Hei Long Jiang Med J"},{"key":"R31-20230914","first-page":"1397","article-title":"The expression of p16 in the precancerous lesion and nasopharyngeal cancer tissue","volume":"33","author":"Huang","year":"2004","journal-title":"Chongqing Med J"},{"key":"R32-20230914","first-page":"142","article-title":"Expression of p16 protein and VEGF in nasopharyngeal carcinoma and its clinical significance","volume":"31","author":"Li","year":"2004","journal-title":"Cancer Prevent Res"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.humpath.2006.01.010","article-title":"Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis","volume":"37","author":"Fan","year":"2006","journal-title":"Hum Pathol"},{"key":"R34-20230914","first-page":"1","article-title":"The relations between expression of p16, p27kip1 and CT in NPC","volume":"8","author":"Li","year":"2006","journal-title":"J Xiangnan Univ (Medical Sciences)"},{"key":"R35-20230914","first-page":"24","article-title":"The relationship between the CT findings and p16 protein abnormal expression of nasopharyngeal carcinoma","volume":"37","author":"Wu","year":"2006","journal-title":"Huangzhou Pharma"},{"key":"R36-20230914","first-page":"664","article-title":"Expression and significance of EGR-1, P53, p16, and Cyclin D1 in nasopharyngeal carcinoma","volume":"18","author":"Zhong","year":"2006","journal-title":"Cancer Res Clin"},{"key":"R37-20230914","first-page":"136","article-title":"The expression and significance of p16, nm23, and PCNA protein in nasopharyngeal carcinoma","volume":"25","author":"Li","year":"2007","journal-title":"Health Vocat Educ"},{"key":"R38-20230914","first-page":"75","article-title":"Expression of p16, p130, and nm23-H1 protein in nasopharyngeal carcinoma","volume":"36","author":"Liang","year":"2007","journal-title":"J Med Sci"},{"key":"R39-20230914","first-page":"1011","article-title":"Immunohistochemical study on the expression of tumor suppressor gene p16 in nasopharyngeal carcinoma in uygurs and hans in xinjiang","volume":"20","author":"Qu","year":"2007","journal-title":"Med Ethics Pract"},{"key":"R40-20230914","first-page":"370","article-title":"The expression of p16 and cyclinD1 in nasopharyngeal carcinoma and its clinical significance","volume":"16","author":"Ji","year":"2010","journal-title":"J Oncol"},{"key":"R41-20230914","first-page":"362","article-title":"Expression and significance of cyclin D1, p16, and Rb protein in nasopharyngeal carcinoma","volume":"15","author":"Chen","year":"1999","journal-title":"J Clin Exp Pathol"},{"key":"R42-20230914","first-page":"14","article-title":"The relationship between C-erb-2, p16, and nm23-H1 prtein expression and prognosis of nasopharyngeal carcinoma","volume":"13","author":"Zhang","year":"2001","journal-title":"Cancer Res Clin"},{"key":"R43-20230914","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/annonc\/mdf215","article-title":"Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy","volume":"13","author":"Hwang","year":"2002","journal-title":"Ann Oncol"},{"key":"R44-20230914","first-page":"342","article-title":"Expression of p16 and nm23-H1 in nasopharyngeal carcinoma and their clinical significance","volume":"25","author":"Chen","year":"2005","journal-title":"J First Mil Med Univ"},{"key":"R45-20230914","first-page":"304","article-title":"Clinical significance of expression of CD15s and p16 in nasopharygeal carcinoma","volume":"36","author":"Gu","year":"2005","journal-title":"J Shanxi Med Univ"},{"key":"R46-20230914","first-page":"464","article-title":"Studies on c-myc gene expression and p16 gene inactivation in nasopharyngeal carcinoma","volume":"35","author":"Zheng","year":"2000","journal-title":"Chin J Otorhinolaryngol"},{"key":"R47-20230914","first-page":"358","article-title":"The clinical significance of p16 protein non-expression and p16 gene inactivation by deletions and hypermethylation in nasopharyngeal carcinoma","volume":"34","author":"Xiang","year":"2005","journal-title":"Chin J Pathol"},{"issue":"(suppl 1)","key":"R48-20230914","first-page":"E1459","article-title":"Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas","volume":"38","author":"Jiang","year":"2016","journal-title":"Head Neck"},{"key":"R49-20230914","first-page":"2177","article-title":"Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma","volume":"9","author":"Makitie","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R50-20230914","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000455901","article-title":"Clinical value of the Epstein-Barr virus and p16 status in patients with nasopharyngeal carcinoma: a single-centre study in Japan","volume":"78","author":"Saito","year":"2016","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R51-20230914","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-4598-10-48","article-title":"Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population","volume":"10","author":"Hutajulu","year":"2011","journal-title":"Mol Cancer"},{"key":"R52-20230914","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/onc.2016.298","article-title":"Sustained p16INK4a expression is required to prevent IR-induced tumorigenesis in mice","volume":"36","author":"Palacio","year":"2017","journal-title":"Oncogene"},{"key":"R53-20230914","first-page":"316","article-title":"Molecular findings of nasopharyngeal carcinoma in a European population","volume":"33","author":"Gonzalez","year":"2011","journal-title":"Anal Quant Cytol Histol"},{"key":"R54-20230914","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/MD.0000000000013752","article-title":"Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: a PRISMA-compliant meta-analysis","volume":"97","author":"Zhou","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R55-20230914","doi-asserted-by":"crossref","first-page":"83270","DOI":"10.18632\/oncotarget.18742","article-title":"Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"R56-20230914","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00125480-199703000-00001","article-title":"Nasopharyngeal carcinoma: classification and histological appearances","volume":"4","author":"Nicholls","year":"1997","journal-title":"Adv Anat Path"},{"key":"R57-20230914","first-page":"e182","article-title":"Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA)","volume":"97","author":"Cao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R58-20230914","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40880-017-0232-5","article-title":"Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review","volume":"36","author":"Wang","year":"2017","journal-title":"Chin J Cancer"},{"key":"R59-20230914","doi-asserted-by":"crossref","first-page":"e7476","DOI":"10.1097\/MD.0000000000007476","article-title":"Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: a systematic meta-analysis under the guideline of PRISMA","volume":"96","author":"Sheng","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903150-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:49:47Z","timestamp":1694728187000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903150-00009"}},"subtitle":["A PRISMA-compliant meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014602","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}